Alyeska Investment Group
HOOK

Alyeska Investment Group’s HOOKIPA Pharma HOOK Stock Holding History

Alyeska Investment Group’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-310,944
Closed -$1.92M – 584
2023
Q3 		$1.92M Hold
310,944
– – 0.01% 390
2023
Q2 		$2.74M Buy
310,944
+298,266
+2,353% +$3.31M 0.02% 387
2023
Q1 		$93.3K Hold
12,678
– – ﹤0.01% 436
2022
Q4 		$103K Buy
+12,678
New +$137K ﹤0.01% 401
2022
Q3 		– Sell
-12,678
Closed -$207K – 429
2022
Q2 		$207K Sell
12,678
-50,210
-80% -$831K ﹤0.01% 550
2022
Q1 		$1.43M Buy
+62,888
New +$1.13M 0.02% 472

Other funds holding HOOK

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Alyeska Investment Group's HOOK Position: Q4 2023 in Review

Alyeska Investment Group sold out of HOOKIPA Pharma (HOOK) in Q4 2023, closing a stake of 310,944 shares — an estimated $1.92M sold.

Alyeska Investment Group first reported a position in HOOK in Q1 2022 and held it in 6 quarters. The position peaked at $2.74M in Q2 2023. 41 funds tracked by Wall St. Rank hold HOOK as of Q4 2023.

  • Alyeska Investment Group reported no remaining HOOKIPA Pharma position as of Q4 2023 after selling out during the quarter.
  • Alyeska Investment Group sold 310,944 HOOKIPA Pharma shares in Q4 2023, an estimated $1.92M.
  • Alyeska Investment Group first reported a position in HOOKIPA Pharma in Q1 2022 and held it in 6 quarters.
  • Alyeska Investment Group's HOOKIPA Pharma position peaked at $2.74M in Q2 2023.
  • 41 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q4 2023.

Based on Alyeska Investment Group's 13F filing for Q4 2023, filed 14 Feb 2024.